Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias
Singh, B.N.
New Zealand Medical Journal 78(504): 482-486
1973
ISSN/ISBN: 0028-8446 PMID: 4130662 Document Number: 58458
Document emailed within 1 workday
Related Documents
Rodrigues, R.; Kornfeld, J.; Pereira, E.M. 1972: Anti-arrhythmic effect of a new adrenergic beta receptor blocking substance Arquivos Brasileiros de Cardiologia 25(6): 471-475Fujita, T.; Miyazaki, M. 1972: Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124 Masui. Japanese Journal of Anesthesiology 21(5): 450-457
Allen, J.D.; Ekue, J.M.; Pantridge, J.F.; Shanks, R.G.; Zaidi, S.A. 1971: Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs British Journal of Anaesthesia 43(7): 720-721
Chen Xiu 1979: Electrophysiological actions and pharmacological evaluation of anti-arrhythmic drugs Yao Xue Xue Bao 14(2): 120-128
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Di Luzio, V.; Purcaro, A.; Curzi, G.; Di Segni, E.; Chiesa, R.; Di Giuseppe, F. 1972: Effects on the contractile state of the myocardium and anti-arrhythmic properties of practolol, a beta-blocking agent with cardioselective activity Bollettino Della Societa Italiana di Cardiologia 17(3): 179-187
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Imai, S. 1975: Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs Nihon Jinzo Gakkai Shi 17(7): 674-677
Alvan, G.; von Bahr, C.; Seidemann, P.; Sjöqvist, F. 1982: High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation Lancet 1(8267): 333
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Krishnarao, K.; Achari, G. 1972: Anti-arrhythmic actions of two newer antihistaminics Journal of the Indian Medical Association 58(1): 1-4
Matta, F.; De Marchi, M.; Pecchio, F.; Bevilacqua, R.; Aillon, A.; Piccinino, C.; Riva, L.; Alvino, A.; Angelino, P.F. 1981: Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct Minerva Cardioangiologica 29(4): 131-136
Rahn, K.H. 1980: The influence of beta receptor blocking drugs on plasma catecholamine levels in patients with essential hypertension Archives Internationales de Pharmacodynamie et de Therapie Suppl: 54-57
Sakura, H.; Togashi, M.; Iwamoto, Y. 2002: Beta 3-adrenergic receptor agonists as anti-obese and anti-diabetic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 60(1): 123-129
Mashiba, H.; Kanaya, S. 1974: Actions of anti-arrhythmic agents on physiology of myocardial cell membrane Nihon Rinsho. Japanese Journal of Clinical Medicine 32(9): 2829-2834
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Rolli, A.; Bonatti, V.; Finardi, A.; Favaro, L.; Botti, G. 1981: Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias Giornale Italiano di Cardiologia 11(4): 468-476
Frank, R.; Fontaine, G.; Coutte, R.; Tonet, J.; Cohen, A.; Grosgogeat, Y. 1981: Reproducibility of ventricular arrhythmias induced before and after drug therapy. Predictive value of their anti-arrhythmic effect Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 79-86